Biosense Webster

Biosense Webster, Inc. is a leader in diagnosing and treating heart rhythm disorders, focusing on electrophysiology technologies. Founded in 1999 and based in Diamond Bar, California, the company employs over 1,300 people across 40 countries. It has a rich history rooted in early catheter innovations by Wilton "Will" W. Webster, Jr., who developed groundbreaking devices in the 1980s. The company offers advanced products such as the CARTO® 3 System, which enhances 3D mapping for electrophysiology procedures, and the NAVISTAR® THERMOCOOL® Catheter, the first FDA-approved therapeutic ablation catheter for atrial fibrillation. Biosense Webster collaborates with clinicians to drive innovations that improve the efficiency and accuracy of procedures, ultimately enhancing patient outcomes in the field of electrophysiology.